Rejection with heart failure after pediatric cardiac transplantation

Annals of Thoracic Surgery

Volumn 68, Issue 1, 1999, Pages 176-180

  Flippin, Mindee J ^a   Balzer, David T ^a   Murphy, Paula R ^a   Ruble, Susan E ^a   Mendeloff, Eric N ^b   Huddleston, Charles B ^b   Canter, Charles E ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; STEROID;

ARTICLE; CHILD; CLINICAL ARTICLE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INFANT; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; INFANT; MALE; MULTIVARIATE ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0032814013     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00476-2     Document Type: Article

References (30)

1. Sethi G.K., Rosado L.J., McCarthy M., Butman S.S., Copeland J.G. Futility of yearly biopsies in patients undergoing heart transplantation. J Thorac Cardiovasc Surg. 104:1992;90-93.
2. Glanville A.R., Imoto E., Baldwin J.C., Billingham M.E., Theodore J., Robin E.D. The role of right ventricular biopsy in the late management of heart-lung transplant recipients. J Heart Transplant. 6:1987;357-361.
3. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation fourteenth official report-1997 . J Heart Lung Transplant. 16:1997;691-712.
4. Boucek M.M., Novick R.J., Bennett L.E., Fiol B., Keck B.M., Hosenpud J.D. The Registry of the International Society of Heart and Lung Transplantation first official pediatric report-1997 . J Heart Lung Transplant. 16:1997;1189-1206.
5. Mills R.M., Naftel D.C., Kirklin J.K., et al. Cardiac transplant rejection with hemodynamic compromise a multi-institutional study of the role of endomyocardial cellular infiltrate . J Heart Lung Transplant. 16:1997;813-821.
6. Shaddy R.E., Naftel D.C., Kirklin J.K., et al. Outcome of cardiac transplantation in children survival in a contemporary multi-institutional experience . Circulation. 94:(Suppl 2):1996;69-73.
7. Kirklin J.K., Naftel D.C., Bourge R.C., et al. Rejection after cardiac transplantation a time-related risk factor analysis . Circulation. 86:(Suppl 2):1992;236-241.
8. Kobashigawa J.A., Kirklin J.K., Naftel D.C., et al. Pretransplantation risk factors for acute rejection after heart transplantation a multiinstitutional study . J Heart Lung Transplant. 12:1993;355-366.
9. Kubo S.H., Naftel D.C., Mills R.M., et al. Risk factors for late recurrent rejection after heart transplantation a multiinstitutional, multivariable analysis . J Heart Lung Transplant. 14:1995;409-418.
10. Laufer G., Miholic J., Laczkovics A., et al. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression. J Thorac Cardiovasc Surg. 98:1989;1113-1121.
11. Jarcho J., Naftel D.C., Shroyer T.W., et al. Influence of HLA mismatch on rejection after heart transplantation a multi-institutional study . J Heart Lung Transplant. 98:1989;1113-1121.
12. Bolling S.F., Putnam J.B. Jr, Abrams G.D., McKay A.M., Deeb G.M. Hemodynamics versus biopsy findings during cardiac transplant rejection. Ann Thorac Surg. 51:1991;52-55.
13. McNamara D., Disalvo T., Mathier M., Keck S., Semigran M., Dec G.W. Left ventricular dysfunction after heart transplantation incidence and role of enhanced immunosuppression . J Heart Lung Transplant. 15:1996;506-515.
14. Balzer D.T., Moorhead S., Saffitz J.E., Huddleston C.B., Spray T.L., Canter C.E. Utility of surveillance biopsies in infant heart transplant recipients. J Heart Lung Transplant. 14:1995;1095-1101.
15. Bernstein D., Clayberger C., Baum D. Pediatric heart transplantation allograft rejection . Prog Pediatr Cardiol. 2:(4):1993;34-41.
16. Chinnock R.E., Baum M.F., Larsen R., Bailey L. Rejection management and long-term surveillance of the pediatric heart transplant recipient the Loma Linda experience . J Heart Lung Transplant. 12:1993;S255-S264.
17. Rotondo K., Naftel D., Boucek R., et al. Allograft rejection following cardiac transplantation in infants and children. A multi-institutional study. [Abstract] J Heart Lung Transplant. 15:1996;580.
18. Canter C.E., Saffitz J.E., Moorhead S., Gutierrez F.R., Bolman R.M., Spray T.L. Early results after pediatric cardiac transplantation with triple immunosuppression therapy. Am J Cardiol. 71:1993;971-975.
19. Canter C.E., Moorhead S., Saffitz J., Huddleston C., Spray T. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression. J Heart Lung Transplant. 13:1994;74-80.
20. Billingham M.E., Cary N.R.B., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection Heart Rejection Study Group . J Heart Lung Transplant. 9:1990;587-593.
21. Malafa M., Mancini M.C., Myles J.L., Gohara A., Dickinson J.M., Walsh T.E. Successful treatment of acute humoral rejection in a heart transplant patient. J Heart Lung Transplant. 11:1992;486-491.
22. Zales V.R., Crawford S., Backer C.L., Lynch P., Benson D.W., Mavroudis C. Spectrum of humoral rejection after pediatric heart transplantation. J Heart Lung Transplant. 12:1993;563-572.
23. Kobashigawa J.A., Moriguchi J.D., Laks H., et al. Successful therapy for cardiac transplant recipients with hemodynamic compromising rejection. Circulation. 93:(Suppl 1):1997;I479.
24. Canter C.E. Current outcomes in pediatric thoracic transplantation. ACC Curr J Rev. 1997;65-68.
25. Canter C.E., Naftel D., Caldwell R., et al. Survival and risk factors for death after cardiac transplantation in infants a multi-institutional study . Circulation. 96:1997;227-231.
26. Bonnaud E.N., Lewis N.P., Masek M.A., Billingham M.E. Reliability and usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant. 14:1995;163-171.
27. Valantine H.A., Hunt S.A., Gibbons R., Billingham M.E., Stinson E.B., Popp R.L. Increasing pericardial effusion in cardiac transplant recipients. Circulation. 79:1989;603-609.
28. Ciliberto G.R., Anjos M.C., Gronda E., et al. Significance of pericardial effusion after heart transplantation. Am J Cardiol. 76:1995;297-300.
29. Bailey L., Zuppan C., Chinnock R., Johnston J., Razzouk A., Gundry S. Graft vasculopathy among recipients of heart transplantation during the first 12 years of life. Transplant Proc. 27:1995;1921-1925.
30. Addonizio L., Hsu D., Kichuk M., et al. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression. Circulation. 88:(Suppl 2):1993;224-229.